Home › Plexiform Neurofibroma › District of Columbia
Plexiform Neurofibroma clinical trials in District of Columbia
4 studies for Plexiform Neurofibroma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Children's National Hospital, Washington D.C.
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Oct 2, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Children's National Hospital, Washington D.C.
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jul 29, 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
- Children's National Medical Center, Washington D.C.
Recruiting
Ages 1 to 120 · All sexes · Updated Jun 9, 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Children's National Hospital, Washington D.C.
RecruitingPhase 2
Ages 1 to 8 · All sexes · Updated May 29, 2026 · NCT06188741From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.